ÂÜÀòÂÒÂ×

Mr. Wu has served as Director of Ansun since July of 2018. Mr. Aimin Wu is the President and Managing Partner of Sinopharm Capital. Prior to that, Mr. Wu served as the Chief Financial Officer of Sinopharm Group Co. Ltd. from July 2003 to December 2006. From 2007 to 2012, Mr. Wu served as the Vice President of Sinopharm Group Co. Ltd. In addition, Mr. Wu was a Director of Accord Pharma from January 2005 to April 2014, a Director of National Medicines from December 2005 to December 2008, and a supervisor of National Medicines from May 2009 to December 2011. Mr. Wu has nearly 20 years of working experience in Chinese and international capital market operations, pharmaceutical industry strategic development, mergers and acquisitions, restructurings, business development, and financial management. Mr. Wu is a qualified accountant in the PRC. He obtained an Executive Master of Business Administration degree from Shanghai Jiao Tong University in December 2006, and a Bachelor’s degree in Engineering, Majoring in Economy, from Hunan University in July 1992.